D. Giacchero

发表

Major clinical response to a BRAF inhibitor in a patient with a BRAF L597R-mutated melanoma.

P. Bahadoran, R. Ballotti, P. Hofman, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype

V. Bonazzi, K. Bille, P. Bahadoran, 2013, Oncotarget.

Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.

P. Bahadoran, G. Poissonnet, J. Emile, 2013, The Journal of investigative dermatology.

Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis

V. Prod’homme, J. Borg, A. Mallavialle, 2015, Nature Communications.

Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study

L. Misery, C. Robert, L. Chiche, 2019, Arthritis & rheumatology.

Assessment of diagnostic criteria between primary cutaneous anaplastic large‐cell lymphoma and CD30‐rich transformed mycosis fungoides; a study of 66 cases

D. Cappellen, J. Merlio, S. Dalle, 2015, The British journal of dermatology.

Defining and recognising locally advanced basal cell carcinoma

J. Grob, B. Dréno, N. Basset-Seguin, 2015, European Journal of Dermatology.

Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

G. Milano, P. Brest, F. Peyrade, 2020, Scientific Reports.

Immune checkpoint inhibitor-induced bullous pemphigoid: Towards a new class of drug-drug interaction?

N. Cardot-Leccia, F. Rocher, D. Giacchero, 2020, European journal of cancer.

Reactivation of cutaneous psoriasis during abatacept therapy for spondyloarthropathy.

C. Roux, D. Giacchero, L. Euller-Ziegler, 2010, Joint, bone, spine : revue du rhumatisme.

[6-mercaptopurine-related hand-foot syndrome in a four-year-old child].

C. Chiaverini, F. Monpoux, J. Lacour, 2008, Annales de dermatologie et de venereologie.

Efficacy of cetuximab for unresectable or advanced cutaneous squamous cell carcinoma--a report of eight cases.

K. Bénézery, F. Peyrade, B. Guillot, 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib.

E. Baudin, M. Schlumberger, C. Robert, 2012, Archives of dermatology.

Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France

S. Dahan, B. Jaillard, M. Rybojad, 2020, Journal of the American Academy of Dermatology.

No correlation between the molecular subtype of COL1A1-PDGFB fusion gene and the clinico-histopathological features of dermatofibrosarcoma protuberans.

Paulo A. S. Nuin, P. Terrier, J. Coindre, 2010, The Journal of investigative dermatology.

308‐nm excimer lamp vs. 308‐nm excimer laser for treating vitiligo: a randomized study

J. Ortonne, J. Lacour, J. Lacour, 2010, The British journal of dermatology.

Kaposi's varicelliform eruption in a patient with pityriasis rubra pilaris (pityriasis rubra pilaris herpeticum)

N. Cardot-Leccia, J. Lacour, T. Passeron, 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner

P. Abbe, P. Bahadoran, C. Bertolotto, 2013, Molecular Cancer Therapeutics.

Immune checkpoint-mediated psoriasis: a multicentric European study of 115 patients from European Network for Cutaneous ADverse Event to Oncologic drugs (ENCADO) group.

A. Lallas, G. Fabbrocini, K. Peris, 2020, Journal of the American Academy of Dermatology.

Signalling and chemosensitivity assays in melanoma: is mutated status a prerequisite for targeted therapy?

P. Bahadoran, J. Ortonne, C. Bertolotto, 2011, Experimental dermatology.

Association of Anti-Programmed Cell Death 1 Antibody Treatment With Risk of Recurrence of Toxic Effects After Immune-Related Adverse Events of Ipilimumab in Patients With Metastatic Melanoma.

J. Grob, C. Lebbé, S. Prey, 2020, JAMA dermatology.

New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?

C. Roux, J. Lacour, C. Perrin, 2007, The Journal of rheumatology.

Regulation of NADPH-dependent Nitric Oxide and reactive oxygen species signalling in endothelial and melanoma cells by a photoactive NADPH analogue

J. Boucher, P. Tauc, E. Deprez, 2014, Oncotarget.

[Stage III melanoma: Sentinel node biopsy, completion lymph node dissection and prospects of adjuvant therapy. A French national survey on current and envisaged practices].

T. Jouary, C. Lebbé, A. Dupuy, 2019 .

A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.

P. Bahadoran, C. Bertolotto, R. Ballotti, 2014, The Journal of investigative dermatology.

Metformin monotherapy in melanoma: a pilot, open‐label, prospective, and multicentric study indicates no benefit

P. Bahadoran, R. Ballotti, S. Rocchi, 2017, Pigment cell & melanoma research.

Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics

G. Milano, P. Brest, F. Peyrade, 2020, Scientific Reports.

MCT-12-1226-T 1605..1615

P. Abbe, P. Bahadoran, C. Bertolotto, 2013 .

Metformin monotherapy is not effective for advanced melanoma

P. Bahadoran, S. Rocchi, V. Hofman, 2017 .